Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells

por Ta, Michelle H. T., Liuwantara, David, Rangan, Gopala K.
Publicado 2015

578. Microbiology Laboratory-Driven Standardized Urine Culture Reporting Increases Aminopenicillin Prescribing in Vancomycin-Resistant Enterococci Urinary Infections

por Cheung, Genevieve, Javier, Diane, Kachouei, Farrnam, Pasiliao, Roxanne, Ta, Michelle, Estevez, Dennys, Bolaris, Michael, Ha, David
Publicado 2019

Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: a secondary use of data analysis of patients in the IMADJIN® dataset

por Thomas, Mark, Gois, Pedro Henrique Franca, Butcher, Belinda E., Ta, Michelle H. T., Van Wyk, Greg W.
Publicado 2021

Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease

por Ta, Michelle H. T., Rao, Padmashree, Korgaonkar, Mayuresh, Foster, Sheryl F., Peduto, Anthony, Harris, David C. H., Rangan, Gopala K.
Publicado 2014

Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease

por Ta, Michelle H. T., Schwensen, Kristina G., Foster, Sheryl, Korgaonkar, Mayuresh, Ozimek-Kulik, Justyna E., Phillips, Jacqueline K., Peduto, Anthony, Rangan, Gopala K.
Publicado 2016